Search research articles
Contact Us
Filters
Showing results (21-30 of 185) with videos related to
Page
of 19
Sort By:
International Immunopharmacology
|
December 31, 2021
Targeting macrophage-mediated tumor cell phagocytosis: An overview of phagocytosis checkpoints blockade, nanomedicine intervention, and engineered CAR-macrophage therapy
Susan Moradinasab, Atieh Pourbagheri-Sigaroodi, Seyed H Ghaffari, et al.
Frontiers in Oncology
|
January 2, 2023
Predictive value of PD-L1 expression in response to immune checkpoint inhibitors for esophageal cancer treatment: A systematic review and meta-analysis
Maryam Noori, Amir-Mohammad Yousefi, Mohammad Reza Zali, et al.
Journal of the Egyptian National Cancer Institute
|
October 6, 2024
Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors
Zeinab Davoodi-Moghaddam, Farideh Jafari-Raddani, Shahram Kordasti, et al.
Journal of Cellular Physiology
|
July 17, 2022
Noncoding RNAs in diagnosis and prognosis of graft-versus-host disease (GVHD)
Mahdi K Vajari, Susan Moradinasab, Amir-Mohammad Yousefi, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
April 3, 2023
Synergistic Effects of PI3K Inhibition on Arsenic Trioxide Cytotoxicity in Acute Promyelocytic Leukemia Cells: A New Portrait of Idelalisib as an Adjuvant Therapy
Maryam Dadashi, Atieh Pourbagheri-Sigaroodi, Ali Anjam-Najmedini, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
June 25, 2024
Anti-Leukemic Effects of Small Molecule Inhibitor of c-Myc (10058-F4) on Chronic Myeloid Leukemia Cells
Sara Zehtabcheh, Negar Sheikh-Zeineddini, Amir-Mohammad Yousefi, et al.
Artificial Cells, Nanomedicine, and Biotechnology
|
April 11, 2020
ZnO/CNT@Fe<sub>3</sub>O<sub>4</sub> induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment
Amir-Mohammad Yousefi, Ava Safaroghli-Azar, Zahra Fakhroueian, et al.
Breast Cancer (Tokyo, Japan)
|
March 28, 2016
Melatonin, an inhibitory agent in breast cancer
Elaheh Nooshinfar, Ava Safaroghli-Azar, Davood Bashash, et al.
Translational Oncology
|
February 11, 2023
A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?
Zeinab Davoodi-Moghaddam, Farideh Jafari-Raddani, Maryam Noori, et al.
International Immunopharmacology
|
August 13, 2022
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
Mahda Delshad, Mohammad-Javad Sanaei, Atieh Pourbagheri-Sigaroodi, et al.
Page
of 19
Search research articles
Search
Showing results (21-30 of 185) with videos related to
Sort By:
Page
of 19
International Immunopharmacology
|
December 31, 2021
Targeting macrophage-mediated tumor cell phagocytosis: An overview of phagocytosis checkpoints blockade, nanomedicine intervention, and engineered CAR-macrophage therapy
Susan Moradinasab, Atieh Pourbagheri-Sigaroodi, Seyed H Ghaffari, et al.
Frontiers in Oncology
|
January 2, 2023
Predictive value of PD-L1 expression in response to immune checkpoint inhibitors for esophageal cancer treatment: A systematic review and meta-analysis
Maryam Noori, Amir-Mohammad Yousefi, Mohammad Reza Zali, et al.
Journal of the Egyptian National Cancer Institute
|
October 6, 2024
Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors
Zeinab Davoodi-Moghaddam, Farideh Jafari-Raddani, Shahram Kordasti, et al.
Journal of Cellular Physiology
|
July 17, 2022
Noncoding RNAs in diagnosis and prognosis of graft-versus-host disease (GVHD)
Mahdi K Vajari, Susan Moradinasab, Amir-Mohammad Yousefi, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
April 3, 2023
Synergistic Effects of PI3K Inhibition on Arsenic Trioxide Cytotoxicity in Acute Promyelocytic Leukemia Cells: A New Portrait of Idelalisib as an Adjuvant Therapy
Maryam Dadashi, Atieh Pourbagheri-Sigaroodi, Ali Anjam-Najmedini, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
June 25, 2024
Anti-Leukemic Effects of Small Molecule Inhibitor of c-Myc (10058-F4) on Chronic Myeloid Leukemia Cells
Sara Zehtabcheh, Negar Sheikh-Zeineddini, Amir-Mohammad Yousefi, et al.
Artificial Cells, Nanomedicine, and Biotechnology
|
April 11, 2020
ZnO/CNT@Fe<sub>3</sub>O<sub>4</sub> induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment
Amir-Mohammad Yousefi, Ava Safaroghli-Azar, Zahra Fakhroueian, et al.
Breast Cancer (Tokyo, Japan)
|
March 28, 2016
Melatonin, an inhibitory agent in breast cancer
Elaheh Nooshinfar, Ava Safaroghli-Azar, Davood Bashash, et al.
Translational Oncology
|
February 11, 2023
A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?
Zeinab Davoodi-Moghaddam, Farideh Jafari-Raddani, Maryam Noori, et al.
International Immunopharmacology
|
August 13, 2022
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
Mahda Delshad, Mohammad-Javad Sanaei, Atieh Pourbagheri-Sigaroodi, et al.
Page
of 19